‘Truly a groundbreaking discovery’: U.Va. gets funding for clinical trial to stop sepsis | NYGazet

A team at the University of Virginia has developed a monoclonal antibody to stop sepsis, the leading cause of death in U.S. hospitals.

A team at the University of Virginia has developed a monoclonal antibody to stop sepsis, the leading cause of death in U.S. hospitals. There is good news from Virginia when it comes to the deadly infection sepsis. “This is truly a groundbreaking disc... [1754 chars]